Intra-host evolutionary dynamics of the hepatitis C virus among people who inject drugs

被引:0
|
作者
Vincent Montoya
Anita Y. M. Howe
Weiyan Y. Dong
Winnie Dong
Chanson J. Brumme
Andrea D. Olmstead
Kanna Hayashi
P. Richard Harrigan
Jeffrey B. Joy
机构
[1] British Columbia Centre for Excellence in HIV/AIDS,Department of Medicine
[2] British Columbia Centre for Disease Control,Faculty of Health Sciences
[3] University of British Columbia,Bioinformatics Program
[4] Simon Fraser University,undefined
[5] British Columbia Centre on Substance Use,undefined
[6] University of British Columbia,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Most individuals chronically infected with hepatitis C virus (HCV) are asymptomatic during the initial stages of infection and therefore the precise timing of infection is often unknown. Retrospective estimation of infection duration would improve existing surveillance data and help guide treatment. While intra-host viral diversity quantifications such as Shannon entropy have previously been utilized for estimating duration of infection, these studies characterize the viral population from only a relatively short segment of the HCV genome. In this study intra-host diversities were examined across the HCV genome in order to identify the region most reflective of time and the degree to which these estimates are influenced by high-risk activities including those associated with HCV acquisition. Shannon diversities were calculated for all regions of HCV from 78 longitudinally sampled individuals with known seroconversion timeframes. While the region of the HCV genome most accurately reflecting time resided within the NS3 gene, the gene region with the highest capacity to differentiate acute from chronic infections was identified within the NS5b region. Multivariate models predicting duration of infection from viral diversity significantly improved upon incorporation of variables associated with recent public, unsupervised drug use. These results could assist the development of strategic population treatment guidelines for high-risk individuals infected with HCV and offer insights into variables associated with a likelihood of transmission.
引用
收藏
相关论文
共 50 条
  • [41] SYMPOSIUM: ENHANCING HEPATITIS C CARE AMONG PEOPLE WHO INJECT DRUGS
    Hajarizadeh, Behzad
    Marshall, Alison D.
    Grebely, Jason
    Dore, Gregory J.
    Treloar, Carla
    Corry, Angela
    Hayllar, Jeremy
    Byrne, Jude
    [J]. DRUG AND ALCOHOL REVIEW, 2019, 38 : S8 - S9
  • [42] Reasons for Not Seeking Hepatitis C Treatment among People Who Inject Drugs
    Morris, Leith
    Selvey, Linda
    Williams, Owain
    Gilks, Charles
    Smirnov, Andrew
    [J]. SUBSTANCE USE & MISUSE, 2020, 56 (02) : 175 - 184
  • [43] PREVALENCE AND PREDICTORS OF HEPATITIS C AMONG YOUNG PEOPLE WHO INJECT DRUGS
    Papanastasiou, Cerissa
    Dietze, Paul
    Higgs, Peter
    Jenkinson, Rebecca
    [J]. DRUG AND ALCOHOL REVIEW, 2011, 30 : 71 - 71
  • [44] Dynamic modeling of hepatitis C transmission among people who inject drugs
    Stocks, Theresa
    Martin, Leah J.
    Kuhlmann-Berenzon, Sharon
    Britton, Tom
    [J]. EPIDEMICS, 2020, 30
  • [45] HEPATITIS C TREATMENT, REINFECTION AND ELIMINATION AMONG PEOPLE WHO INJECT DRUGS
    Hajarizadeh, Behzad
    [J]. DRUG AND ALCOHOL REVIEW, 2019, 38 : S9 - S9
  • [46] Results of hepatitis C treatment program among people who inject drugs
    Filippovych, S.
    Burgay, O.
    Pavlyiuk, I.
    [J]. JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S737 - S737
  • [47] Mitochondrial Genotoxicity of Hepatitis C Treatment among People Who Inject Drugs
    Durand, Melusine
    Nagot, Nicolas
    Nhu, Quynh Bach Thi
    Vallo, Roselyne
    Thuy, Linh Le Thi
    Duong, Huong Thi
    Thanh, Binh Nguyen
    Rapoud, Delphine
    Quillet, Catherine
    Tran, Hong Thi
    Michel, Laurent
    Tuyet, Thanh Nham Thi
    Hai, Oanh Khuat Thi
    Hai, Vinh Vu
    Feelemyer, Jonathan
    Vande Perre, Philippe
    Jarlais, Don Des
    Minh, Khue Pham
    Laureillard, Didier
    Moles, Jean-Pierre
    [J]. JOURNAL OF CLINICAL MEDICINE, 2021, 10 (21)
  • [48] Spatiotemporal Phylodynamics of Hepatitis C Among People Who Inject Drugs in India
    Clipman, Steven J.
    Mehta, Shruti H.
    Rodgers, Mary A.
    Duggal, Priya
    Srikrishnan, Aylur K.
    Saravanan, Shanmugam
    Balakrishnan, Pachamuthu
    Vasudevan, Canjeevaran K.
    Ray, Stuart C.
    Kumar, Muniratnam S.
    Quinn, Thomas C.
    Cloherty, Gavin A.
    Lucas, Gregory M.
    Solomon, Sunil S.
    [J]. HEPATOLOGY, 2021, 74 (04) : 1782 - 1794
  • [49] Moving the Agenda Forward: The Prevention and Management of Hepatitis C Virus Infection Among People Who Inject Drugs
    Grebely, Jason
    Bruggmann, Philip
    Backmund, Markus
    Dore, Gregory J.
    [J]. CLINICAL INFECTIOUS DISEASES, 2013, 57 : S29 - S31
  • [50] Hepatitis C virus treatment as prevention in people who inject drugs: testing the evidence
    Hickman, Matthew
    De Angelis, Daniela
    Vickerman, Peter
    Hutchinson, Sharon
    Martin, Natasha Kaleta
    [J]. CURRENT OPINION IN INFECTIOUS DISEASES, 2015, 28 (06) : 576 - 582